Bluebird Bio reported $-234798000 in EBITDA for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acceleron Pharma XLRN:US $ -62.63M 0.05M
Agios Pharmaceuticals AGIO:US $ -88.87M 0.13M
Alexion Pharmaceuticals ALXN:US $ 892.3M 186.4M
Alnylam Pharmaceuticals ALNY:US $ -134.35M 39.3M
Amgen AMGN:US $ 3188M 218M
Applied Genetic Technologies AGTC:US $ -13.81M 0.55M
Arrowhead Research ARWR:US $ -29868000 3.56M
Avrobio Inc AVRO:US $ -31076000 4.48M
Biogen BIIB:US $ 1147.6M 41.7M
Biomarin Pharmaceutical BMRN:US $ 41.16M 14.24M
Bluebird Bio BLUE:US $ -234.8M 9.32M
Dicerna Pharmaceuticals DRNA:US $ -38.58M 10.29M
Gilead Sciences GILD:US $ 2816M 669M
Immunogen IMGN:US $ -26.83M 1.54M
Intercept Pharmaceuticals ICPT:US $ 1.39M 29.71M
IONIS PHARMACEUT IONS:US $ -68.34M 19.17M
Mirati Therapeutics MRTX:US $ -163.78M 31.65M
Moderna Inc MRNA:US 3.13B 1.85B
Nektar Therapeutics NKTR:US $ -106.66M 0.81M
Novartis NOVN:VX SF 4772M 423M
Pfizer PFE:US $ 7593M 610M
Ptc Therapeutics PTCT:US $ -83.51M 1.05M
Regeneron Pharmaceuticals REGN:US $ 3418.3M 2238.2M
Sangamo Biosciences SGMO:US $ -46.46M 2.03M
Sarepta Therapeutics SRPT:US $ -159.13M 26.19M
Seattle Genetics SGEN:US $ -73.78M 33.35M
Ultragenyx Pharmaceutical RARE:US $ -79.66M 23.55M
Vertex Pharmaceuticals VRTX:US $ -5.12M 917.88M
YTE INCY:US $ 169.77M 41.12M